Zydus Lifesciences has secured USFDA approval to market its generic Ketoconazole Shampoo for treating dandruff and fungal ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences receives USFDA approval to market Ketoconazole Shampoo, a generic antifungal medication for dandruff, ...

Zydus Lifesciences Limited received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture ...

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral Shampoo, 2%).

Zydus Lifesciences stock faces resistance at ₹920 and ₹940, with a downtrend likely to continue despite recent recovery.

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.

Zydus Lifesciences is developing a combination vaccine targeting shigellosis and typhoid, with support from the Gates ...

Zydus Lifesciences has launched VaxiFlu-4, India’s first quadrivalent flu vaccine to offer better protection against ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...